Roche

Diggelmann leaves Roche’s diagnostics division

https://pharmaphorum.com/news/diggelmann-leaves-roche/

Breakthrough designation for Roche/Novartis’ Xolair in food allergies

https://pharmaphorum.com/news/breakthrough-designation-for-roche-novartis-xolair-in-food-allergies/

Drug firms fight US government’s Iraq corruption probe

https://pharmaphorum.com/news/drug-firms-fight-us-governments-iraq-corruption-probe/

New Huntington’s drug granted priority designation

https://pharmaphorum.com/news/huntingtons-drug-granted-priority-designation/

Roche’s MS drug Ocrevus earns blockbuster status a year after launch

https://pharmaphorum.com/news/roche-ms-ocrevus-blockbuster/

Pfizer backed off, but the price hike game continues

https://pharmaphorum.com/news/pfizer-backed-off-but-the-price-hike-game-continues/

Roche to file Tecentriq in triple negative breast cancer

https://pharmaphorum.com/news/roche-files-tecentriq-triple-negative-breast-cancer/

NICE okays Roche rare lung cancer drug after price cut

https://pharmaphorum.com/market-access-2/nice-okays-roche-rare-lung-cancer-drug-after-price-cut/

NICE okays NHS funding for MS and eczema drugs

https://pharmaphorum.com/news/nice-okays-nhs-funding-for-ms-and-eczema-drugs/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search